Abstract
<b><i>Objective:</i></b> To assess the efficacy of the combination of hyperbaric oxygen (HBO) and pharmacological treatment in patients with idiopathic sudden sensorineural hearing loss (ISSNHL) and define patients amenable for HBO therapy. <b><i>Methods:</i></b> Prospective, randomized, trial involving 136 cases with unilateral ISSNHL that were randomly divided into 2 groups: the pharmacological treatment (P) group and HBO + pharmacological treatment (HBO+P) group, which received additional HBO for 14 days besides the pharmacological treatments. Pure tone audiometry gain larger than 15 dBHL was defined as success, and the success rate of each group was calculated. <b><i>Results:</i></b> The overall success rate of the HBO+P group and the P group is 60.6% (40/66) and 42.9% (30/70), respectively (<i>p</i> < 0.05). Furthermore, patients with mild-moderate baseline hearing loss, aged ≤50 years, receiving treatment in ≤14 days, or without accompanied dizziness/vertigo in the HBO+P group had higher success rate than the P group (<i>p</i> < 0.05). <b><i>Conclusions:</i></b> HBO combined with pharmacological treatments leads to better hearing recovery than pharmacological treatments alone.
Subject
Speech and Hearing,Sensory Systems,Otorhinolaryngology,Physiology
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献